Montegen tablets 10 mg No. 30

Montag film-coated tablets are indicated for:

Composition

active ingredient: montelukast;

1 tablet contains 10 mg of montelukast (as montelukast sodium);

excipients: lactose, mannitol (E 421), croscarmellose sodium, hydroxypropylcellulose, microcrystalline cellulose, magnesium stearate, Opadry yellow 20A520007 shell: hypromellose, hydroxypropylcellulose, titanium dioxide (E 171), yellow iron oxide (E 172), red iron oxide (E 172), carnauba wax.

Contraindication

Hypersensitivity to the components of the drug.

Method of application

The drug is intended for use in adults and children over 15 years of age.

Patients with asthma and allergic rhinitis (seasonal and perennial) 1 tablet 10 mg 1 time per day. For the treatment of asthma or asthma in combination with seasonal allergic rhinitis in adults and children over 15 years of age, the recommended dose is 1 tablet 10 mg 1 time per day, in the evening. To relieve the symptoms of allergic rhinitis, the time of administration is selected individually.

The dosage of the drug is the same for male and female patients.

Application features

Pregnant women

Montelukast can be taken during pregnancy only if, in the opinion of the doctor, the expected benefit to the mother outweighs the possible risk to the fetus.

Children

Used in children over 15 years of age. Children under 15 years of age should use the drug in the form of chewable tablets with the appropriate dosage.

Drivers

Montelukast is not expected to affect the patient's ability to drive or use machines. However, drowsiness or dizziness have been reported very rarely.

Overdose

There is no information on the treatment of overdose with montelukast. In chronic asthma studies, montelukast has been administered at doses up to 200 mg/day to adult patients for 22 weeks, and in short-term studies, up to 900 mg/day for approximately one week, with no clinically significant adverse reactions.

Treatment is symptomatic.

Side effects

Interaction

Montelukast can be administered with other drugs for the prevention or long-term treatment of asthma and the treatment of allergic rhinitis. In drug-drug interaction studies, the recommended dose of montelukast had no clinically significant effect on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (ethinylestradiol/norethindrone 35/1), terfenadine, digoxin, and warfarin.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Shelf life - 3 years.